Cumberland Pharmaceuticals (CPIX) Reports Q3 EPS of $0.04

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of $0.04, versus $0.10 reported last year. Revenue for the quarter came in at $7.9 million, versus $9.73 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Prenetics Global (PRE) Tops Q2 EPS by 18c
• Benchmark Reiterates Speculative Buy Rating on Nephros (NEPH) Following Strong Q2 Results